Does Mounjaro Affect Sperm? What the Evidence Shows

What the prescribing data and early research actually show

A question our prescribers hear most weeks (particularly from men who are planning a family) is whether starting tirzepatide could reduce their chances of conceiving. It is a fair thing to ask. The honest answer is that the evidence available right now does not point to harm, but the dataset is limited.

Pre-clinical animal studies, which regulators require before any medicine is licensed, did not find evidence of male reproductive toxicity at tirzepatide exposures comparable to those seen in people. Those findings informed the approval of Mounjaro by the MHRA for use in the UK. In clinical trials (including SURMOUNT-1, which followed thousands of adults over 72 weeks) no signal of impaired male fertility emerged as a reported outcome. You can review the patient-level prescribing information in the Mounjaro SmPC on the eMC, which documents known and suspected effects in full.

Black Triangle (▼) status means the MHRA continues to collect post-marketing safety data as real-world use grows. That ongoing surveillance is how new signals get caught early — but as things stand, male reproductive toxicity is not among the effects flagged. If you want to understand tirzepatide's full safety profile, the NHS tirzepatide medicines page is a reliable starting point.

The other side of the coin: what weight loss tends to do for male hormones

This is the part the headline question often misses. Obesity in men is strongly associated with lower testosterone, elevated oestrogen, poorer sperm motility, and reduced overall fertility. Fat tissue (particularly visceral fat) converts testosterone to oestrogen through a process called aromatisation, and carrying significant excess weight can suppress the hormonal signals the testes depend on.

Meaningful weight reduction, regardless of how it is achieved, tends to reverse some of these effects. Men who lose a clinically significant amount of weight commonly see testosterone rise and sperm parameters improve. If tirzepatide helps someone achieve that reduction, the net reproductive effect could well be positive rather than neutral. This is not a guarantee (fertility is shaped by many factors) but it is the direction the existing evidence points.

It is also worth reading about how Mounjaro affects menstrual cycles if your partner is also on treatment, since the hormonal picture is different and some of the considerations around conception planning overlap.

Contraception, timing, and what to discuss before you try to conceive

Male fertility is one dimension of the picture; conception planning involves both partners. The MHRA advises that women should use contraception while on GLP-1 medicines and for a wash-out period before actively trying to conceive. If your partner is taking tirzepatide or semaglutide, that guidance applies to her, her prescriber will advise on timing. The effect of Mounjaro on oral contraception is a related question worth reading about separately.

For men on Mounjaro who are planning a family, there is no published guidance recommending that they stop treatment before trying to conceive, the evidence does not currently support that precaution. What is sensible is telling your prescriber about your plans so the conversation is part of your clinical review from the start. Weight management treatment decisions do not happen in isolation from the rest of your health.

If sleep quality has also been a concern, the relationship between Mounjaro and sleep is another area patients often ask about, since obstructive sleep apnoea is both a common comorbidity of obesity and a condition that can affect testosterone independently.

How to have this conversation before you start

The safest approach is straightforward: raise your fertility plans explicitly during your consultation. That is true whether you are considering Mounjaro for the first time or reviewing an existing prescription. A prescriber who knows your full picture (age, partner's situation, any previous fertility investigations, other medicines you take) can give you a genuinely personalised answer rather than a general one.

At nume, every consultation is read by a GPhC-registered Independent Prescriber, not processed by software. There is real clinical judgement applied to your answers. If fertility is part of your thinking, include it, the prescriber will factor it in. You can also read about Mounjaro and HRT interactions if hormonal context is relevant to your household.

For a broader overview of tirzepatide as a treatment (how it works, what the eligibility criteria look like, and the process of starting) the tirzepatide treatment guide covers the essentials in plain language. When you are ready to speak with a prescriber, start your free consultation and include any fertility questions in your health history.